{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:28:21Z","timestamp":1793924901644,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016308","name":"Wuxi Health and Family Planning Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016308","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.colsurfb.2026.116125","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:57:58Z","timestamp":1788188278000},"page":"116125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A copper-based nanotherapeutic overcomes multidrug- resistant breast cancer by blocking drug efflux and triggering cuproptosis"],"prefix":"10.1016","volume":"269","author":[{"given":"Shixu","family":"Kou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangda","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4485-8872","authenticated-orcid":false,"given":"Zhaoqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2026.116125_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic antisense oligonucleotides are coming of age","volume":"70","author":"Bennett","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.colsurfb.2026.116125_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202505100","article-title":"Orchestrated photothermal nanoreactor promoted cuproptosis for synergistic cancer therapy through glutathione depletion and gene regulation","volume":"15","author":"Cao","year":"2026","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.colsurfb.2026.116125_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201703083","article-title":"Multifunctional glyco-nanofibers: siRNA induced supermolecular assembly for codelivery in vivo","volume":"27","author":"Chang","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.colsurfb.2026.116125_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12967-025-06121-1","article-title":"Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications","volume":"23","author":"Cong","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.colsurfb.2026.116125_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/genes13091593","article-title":"Breast cancer genetics: diagnostics and treatment","volume":"13","author":"Criscitiello","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.colsurfb.2026.116125_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.actbio.2025.11.028","article-title":"Targeting cuproptosis with nanomaterials for cancer immunotherapy","volume":"209","author":"Cui","year":"2026","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2026.116125_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108488","article-title":"Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): an updated review","volume":"249","author":"Dong","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.colsurfb.2026.116125_bib8","article-title":"Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal","volume":"4","author":"Eljack","year":"2022","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.colsurfb.2026.116125_bib9","doi-asserted-by":"crossref","first-page":"23827","DOI":"10.1021\/acsnano.4c09027","article-title":"Carrier-free nanodrugs: from bench to bedside","volume":"18","author":"Fang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.116125_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1050928","article-title":"Nanocarriers containing platinum compounds for combination chemotherapy","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12964-024-01625-7","article-title":"Cuproptosis: unveiling a new frontier in cancer biology and therapeutics","volume":"22","author":"Feng","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.colsurfb.2026.116125_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102351","article-title":"Mechanistic insights into ASO-RNA complexation: Advancing antisense oligonucleotide design strategies","volume":"35","author":"Horberg","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.colsurfb.2026.116125_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12951-022-01661-w","article-title":"New anti-cancer explorations based on metal ions","volume":"20","author":"Hu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.14715\/cmb\/2023.69.14.46","article-title":"Bcl-2 expression in cell lines breast cancer and death program","volume":"69","author":"Janaghard","year":"2023","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.colsurfb.2026.116125_bib15","doi-asserted-by":"crossref","first-page":"21639","DOI":"10.1021\/acsnano.3c06803","article-title":"Red blood cell-derived extracellular vesicles display endogenous antiviral effects and enhance the efficacy of antiviral oligonucleotide therapy","volume":"17","author":"Jayasinghe","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.116125_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jconrel.2020.10.014","article-title":"Carrier-free nanodrugs for safe and effective cancer treatment","volume":"329","author":"Karaosmanoglu","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.116125_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2021.0459","article-title":"Breast cancer: presentation, investigation and management","volume":"83","author":"Katsura","year":"2022","journal-title":"Br. J. Hosp. Med."},{"key":"10.1016\/j.colsurfb.2026.116125_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041320","article-title":"Targeted therapy and mechanisms of drug resistance in breast cancer","volume":"15","author":"Kinnel","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.116125_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13312-020-1736-7","article-title":"Antisense oligonucleotides: a unique treatment approach","volume":"57","author":"Krishnan","year":"2020","journal-title":"Indian. Pediatr."},{"key":"10.1016\/j.colsurfb.2026.116125_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43856-023-00419-1","article-title":"Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders","volume":"4","author":"Lauffer","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.colsurfb.2026.116125_bib21","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.1039\/D1SC03516A","article-title":"Cancer therapeutic strategies based on metal ions","volume":"12","author":"Liu","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.colsurfb.2026.116125_bib22","article-title":"An Ellagic Acid coordinated copper-based nanoplatform for efficiently overcoming cancer chemoresistance by cuproptosis and synergistic inhibition of cancer cell stemness","volume":"20","author":"Lu","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2026.116125_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1426211","article-title":"Metal ions in biomedically relevant macromolecular structures","volume":"12","author":"Majorek","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.colsurfb.2026.116125_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/asia.202400934","article-title":"Cuproptosis: a copper-mediated programmed cell death","volume":"20","author":"Meena","year":"2025","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.colsurfb.2026.116125_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-0716-4418-8_3","article-title":"Design and preliminary screen of antisense oligonucleotides","volume":"2905","author":"Mor","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib26","first-page":"1028","article-title":"Nanocarriers for delivery of siRNA as gene silencing mediator","volume":"21","author":"Morales-Becerril","year":"2022","journal-title":"EXCLI J."},{"key":"10.1016\/j.colsurfb.2026.116125_bib27","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1021\/acsnano.3c09027","article-title":"An endosomal escape trojan horse platform to improve cytosolic delivery of nucleic acids","volume":"18","author":"Narum","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.116125_bib28","article-title":"Strengthening antisense oligonucleotide-mediated anti-tumor immunity via metal-organic framework nanoparticles","author":"Nowak","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.colsurfb.2026.116125_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acsami.9b20707","article-title":"Aptamer-functionalized DNA origami for targeted codelivery of antisense oligonucleotides and doxorubicin to enhance therapy in drug-resistant cancer cells","volume":"12","author":"Pan","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2026.116125_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11171","article-title":"P-glycoprotein and cancer: what do we currently know?","volume":"8","author":"Pilotto Heming","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.colsurfb.2026.116125_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2021.102793","article-title":"Breast cancer resistance to chemotherapy: when should we suspect it and how can we prevent it?","volume":"70","author":"Prihantono","year":"2021","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.colsurfb.2026.116125_bib32","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1021\/acssynbio.3c00650","article-title":"Nano-regulation of gene expression in Chlamydomonas reinhardtii: harnessing aunps for remotely switchable lipid biosynthesis via antisense oligonucleotides","volume":"13","author":"Rafiei","year":"2024","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jconrel.2022.10.050","article-title":"Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics","volume":"352","author":"Ramasamy","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.116125_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2022.12.047","article-title":"Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics","volume":"354","author":"Ramasamy","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.116125_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/17460441.2024.2440095","article-title":"Evolution of antisense oligonucleotides: navigating nucleic acid chemistry and delivery challenges","volume":"20","author":"Ruchi","year":"2025","journal-title":"Expert. Opin. Drug. Discov."},{"key":"10.1016\/j.colsurfb.2026.116125_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.colsurfb.2026.116125_bib37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/17425255.2021.1992382","article-title":"Antisense oligonucleotides: absorption, distribution, metabolism, and excretion","volume":"17","author":"Shadid","year":"2021","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12951-023-01771-z","article-title":"Metal ions and nanometallic materials in antitumor immunity: Function, application, and perspective","volume":"21","author":"Shen","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib39","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12032-025-03066-9","article-title":"Triple-negative breast cancer: challenges, advances, and promising therapeutic interventions","volume":"42","author":"Sood","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119337","article-title":"Advances in siRNA delivery strategies for the treatment of MDR cancer","volume":"274","author":"Subhan","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.colsurfb.2026.116125_bib41","article-title":"Nanodrug-engineered exosomes achieve a jointly dual-pathway inhibition on cuproptosis","volume":"12","author":"Sun","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.colsurfb.2026.116125_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140148","article-title":"A hyaluronic acid modified copper-based metal-organic framework overcomes multidrug resistance via two-way redox dyshomeostasis under hypoxia","volume":"300","author":"Sun","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib43","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib44","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2174\/1874467216666221017122105","article-title":"Mechanistic features and therapeutic implications related to the MiRNAs and Wnt signaling regulatory in breast cancer","volume":"16","author":"Talebi","year":"2023","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26094179","article-title":"Mapping the role of P-gp in multidrug resistance: insights from recent structural studies","volume":"26","author":"Tia","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.116125_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122223","article-title":"Copper homeostasis and cuproptosis in mitochondria","volume":"334","author":"Tian","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.colsurfb.2026.116125_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120762","article-title":"A hyaluronic acid modified cuprous metal-organic complex for reversing multidrug resistance via redox dyshomeostasis","volume":"311","author":"Wan","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.colsurfb.2026.116125_bib48","doi-asserted-by":"crossref","first-page":"14737","DOI":"10.1007\/s00210-025-04263-z","article-title":"Cuproptosis: the mechanisms of copper-induced cell death and its implication in colorectal cancer","volume":"398","author":"Wang","year":"2025","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101018","article-title":"Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance","volume":"72","author":"Wang","year":"2024","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.colsurfb.2026.116125_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201178","article-title":"Engineering CpG-ASO-Pt-loaded macrophages (CAP@M) for synergistic chemo-\/gene-\/immuno-therapy","volume":"11","author":"Wang","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.colsurfb.2026.116125_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115073","article-title":"RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges","volume":"201","author":"Won Lee","year":"2023","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2026.116125_bib52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","article-title":"Cuproptosis: mechanisms and links with cancers","volume":"22","author":"Xie","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116125_bib53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jconrel.2022.01.012","article-title":"RNA interference (RNAi)-based plasmonic nanomaterials for cancer diagnosis and therapy","volume":"342","author":"Yoon","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.116125_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117486","article-title":"The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents","volume":"95","author":"Yu","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.colsurfb.2026.116125_bib55","article-title":"Polymeric nanocarriers for therapeutic gene delivery","volume":"20","author":"Zhang","year":"2025","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2026.116125_bib56","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/jam.15640","article-title":"Nanocarriers for combating biofilms: advantages and challenges","volume":"133","author":"Zhang","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.colsurfb.2026.116125_bib57","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1021\/acsabm.2c00343","article-title":"Spatio-temporal controlled gene-chemo drug delivery in a DNA nanocomplex to overcome multidrug resistance of cancer cells","volume":"5","author":"Zhao","year":"2022","journal-title":"ACS Appl. Bio Mater."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526007137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526007137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:04:00Z","timestamp":1793923440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526007137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":57,"alternative-id":["S0927776526007137"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116125","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A copper-based nanotherapeutic overcomes multidrug- resistant breast cancer by blocking drug efflux and triggering cuproptosis","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116125"}}